Showing results (231-240 of 375) with videos related to

Sort By:
Pageof 38
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|January 10, 2025
[18F]FDG PET/CT in Necrotizing Fasciitis: A Case Series Investigating the Clinical Utility in a Challenging and Rare ConditionParth Baberwal, Priyanka Verma, Pravin Shinde, et al.
Clinical Nuclear Medicine|November 7, 2009
Early documentation of therapeutic response at 6 weeks following corticosteroid therapy in extensive sarcoidosis: promise of FDG-PETSandip Basu, Ramesh V Asopa, Nawab S Baghel
World Journal of Nuclear Medicine|May 4, 2026
Small Cell Transformation of Metachronous ALK + ve Lung and Prostatic Adenocarcinoma following Initial Response to Ceritinib and Androgen Deprivation Therapies and Metastases to Two Different Organs: Guidance through FDG-PET/CT and 68 Ga-PSMA-11 PET-CT and Biopsy-Immunohistochemistry CorrelationRangat Bagasariya, Keerti Sitani, Trupti Pai, et al.
PET Clinics|May 10, 2016
Exploring Tumor Biology with Fluorodeoxyglucose-Positron Emission Tomography Imaging in Breast CarcinomaSandip Basu, Rakesh Kumar, Ayşe Mavi, et al.
Clinical Nuclear Medicine|November 17, 2023
68 Ga-PSMA-11 PET/CT and 64 CuCl 2 PET/CT Help in Identifying Rare Metastatic Site of Penile Shaft in a Patient of Carcinoma ProstatePriyanka Verma, Aamir Nazar, Sonali Jadhav, et al.
Molecular Imaging and Biology|December 17, 2010
Clinical utility of FDG-PET and PET/CT in non-malignant thoracic disordersSandip Basu, Babak Saboury, Tom Werner, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 19, 2011
PET and PET/CT in the management of thyroid cancerSandip Basu, Muammer Urhan, Joshua Rosenbaum, et al.
Nuclear Medicine Communications|February 6, 2009
Impact of fluorodeoxyglucose PET on the management of esophageal cancerAli Salavati, Sandip Basu, Pedram Heidari, et al.
Nuclear Medicine Communications|October 12, 2018
Resistant functioning and/or progressive symptomatic metastatic gastroenteropancreatic neuroendocrine tumors: efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy in this settingAshwini Kalshetty, Anant Ramaswamy, Vikas Ostwal, et al.
Clinical Nuclear Medicine|November 27, 2025
Rare Site Colonic Metastasis in Renal Cell Carcinoma: Imaging Features on CECT and Multitracer PET-CT Employing 18F-FDG, 68Ga-FAPI-04, and 68Ga-PSMA-11Shivam Gupta, Sunita Sonavane, Subhash Yadav, et al.
Pageof 38